918 Treatment-related adverse event (TRAE)-related discontinuation rate of immunotherapy alone (IO-only) compared to immunotherapy combined with chemotherapy (chemo-IO): a meta-analysis | Zendy

AI Assistant Blog Pricing

918 Treatment-related adverse event (TRAE)-related discontinuation rate of immunotherapy alone (IO-only) compared to immunotherapy combined with chemotherapy (chemo-IO): a meta-analysis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.